Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors
Phase 1
Active, not recruiting
- Conditions
- Squamous Cell Carcinoma of the LungMyxoid/Round Cell LiposarcomaHepatocellular CarcinomaMerkel Cell Carcinoma
- Interventions
- First Posted Date
- 2021-11-15
- Last Posted Date
- 2025-08-15
- Lead Sponsor
- Sotio Biotech Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT05120271
- Locations
- 🇺🇸
Hoag Hospital Newport Beach, Newport Beach, California, United States
🇺🇸Baylor Scott and White Research Institute, Dallas, Texas, United States
🇺🇸University of Texas MD Anderson Cancer Center, Houston, Texas, United States
News
No news found